Interferon-alpha

One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.

Also Known As:

Interferon Alfa; IFN-alpha D; IFN-alpha5; Interferon alpha-1; Interferon alpha-17; Interferon alpha-4; Interferon alpha-5; Interferon alpha-7; Interferon alpha-88; Interferon alpha-J; Interferon alpha-T; Interferon alpha4; Interferon alpha5; Interferon, Lymphoblastoid; Interferon, alpha; LeIF I; LeIF J; Leif D; IFN alpha D; IFN alpha5; Interferon alpha; Interferon alpha 1; Interferon alpha 17; Interferon alpha 4; Interferon alpha 5; Interferon alpha 7; Interferon alpha 88; Interferon alpha J; Interferon alpha T; Leukocyte Interferon; Lymphoblast Interferon; Lymphoblastoid Interferon; alpha Interferon; Interferon, Leukocyte; Interferon, Lymphoblast; alpha-Interferon

Pharmalogical Action Categories:

Antiviral Agents
Immunologic Factors

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Intercellular Signaling Peptides and Proteins: 30151
    - Cytokines: 168239
      - Interferons: 40004
        Interferon Type I: 5027
        Interferon-alpha: 11723
- Peptides: 84029
  - Intercellular Signaling Peptides and Proteins: 30151
    - Cytokines: 168239
      - Interferons: 40004
        Interferon Type I: 5027
        Interferon-alpha: 11723
Biological Factors: 2560
- Intercellular Signaling Peptides and Proteins: 30151
  - Cytokines: 168239
    - Interferons: 40004
      - Interferon Type I: 5027
        Interferon-alpha: 11723

B Vucelić Selected Research

B Vucelić Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure